1. Home
  2. RFAM vs QTRX Comparison

RFAM vs QTRX Comparison

Compare RFAM & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RFAM

RF Acquisition Corp III Ordinary Shares

SELL

Current Price

$9.99

Market Cap

139.5M

Sector

N/A

ML Signal

SELL

Logo Quanterix Corporation

QTRX

Quanterix Corporation

SELL

Current Price

$3.09

Market Cap

160.0M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
RFAM
QTRX
Founded
2025
2007
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
139.5M
160.0M
IPO Year
2025
2017

Fundamental Metrics

Financial Performance
Metric
RFAM
QTRX
Price
$9.99
$3.09
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
★ $3.17
AVG Volume (30 Days)
34.6K
★ 633.6K
Earning Date
N/A
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $37,632,000.00
Revenue This Year
N/A
$3.21
Revenue Next Year
N/A
$9.96
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 64.52
52 Week Low
$9.77
$2.15
52 Week High
$10.02
$8.77

Technical Indicators

Market Signals
Indicator
RFAM
QTRX
Relative Strength Index (RSI) 56.37 45.94
Support Level $9.77 $2.89
Resistance Level $10.02 $3.88
Average True Range (ATR) 0.00 0.26
MACD -0.00 -0.05
Stochastic Oscillator 40.00 1.49

Price Performance

Historical Comparison
RFAM
QTRX

About RFAM RF Acquisition Corp III Ordinary Shares

RF Acquisition Corp III is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: